"76177-196"

655 Results

Sort by

Refrigerated Floorstanding X4FR Centrifuges

Supplier: Thermo Scientific

Standzentrifugen der Thermo Scientific™ X-Serie bieten unübertroffene Leistung und nachhaltige Performance durch die Kombination von fortschrittlicher Touchscreen-Steuerung, nahtloser Konnektivität und Compliance-fähiger Vielseitigkeit für eine Steigerung der Laborforschung. Diese gekühlten Modelle (mit einem natürlichen Kältemittel-Kühlsystem der nächsten Generation, R290, mit einem Treibhauspotenzial (GWP) von nur drei) sind als Geräte für den allgemeinen Gebrauch oder als IVD-MD-Geräte erhältlich.

Expand 2 Items

TT-Etiketten B1-CRYO, 15x5mm weiss 3bahnig zu CITIZEN und DMX E-Class,ohne Perfo 7500 Etik/R., empf. Farbb. SDR-SK, ID 40 mm Speziel l für Cryo-Anwendungen -196°C bis +130°C Resistent gegen die meisten Umwelteinflüsse 1 * 1 Rolle

Supplier: MARKET SOURCE PART PROCESS

TT-Etiketten B1-CRYO, 15x5mm weiss 3bahnig zu CITIZEN und DMX E-Class,ohne Perfo 7500 Etik/R., empf. Farbb. SDR-SK, ID 40 mm Speziel l für Cryo-Anwendungen -196°C bis +130°C Resistent gegen die meisten Umwelteinflüsse 1 * 1 Rolle

Expand 1 Items

Anti-Amyloid beta-peptide Mouse Monoclonal Antibody [clone: MOAB-2]

Supplier: Biosensis

The amyloid beta peptide is derived from the cleavage of the Amyloid precursor protein (APP) and varies in length from 39 to 43 amino acids. However, the form(s) of amyloid-beta peptide (Aβ) associated with the pathology characteristic of Alzheimer’s disease (AD) remains unclear. In particular, the neurotoxicity of intraneuronal Aβ accumulation is an area of considerable research and controversy principally because antibodies thought to be specific for Aβ have been shown to actually detect intraneuronal APP and not Aβ exclusively. MOAB-2 (mouse IgG2b) is a pan-specific, high-titer antibody to Aβ residues 1-4 as demonstrated by biochemical and immunohistochemical analyses (IHC), and is highly specific just to amyloid beta peptide. MOAB-2 did not detect APP or APP-CTFs in cell culture media/lysates (HEK-APPSwe or HEK APPSwe/BACE1) or in brain homogenates from transgenic mice expressing 5 familial AD (FAD) mutation (5xFAD mice). Using IHC on 5xFAD brain tissue, MOAB-2 immunoreactivity co-localized with C-terminal antibodies specific for Aβ40 and Aβ42. MOAB-2 did not co-localize with either N- or C-terminal antibodies to APP. In addition, no MOAB-2-immunreactivity was observed in the brains of 5xFAD/BACE-/- mice, although significant amounts of APP were detected by N- and C-terminal antibodies to APP, as well as by 6E10. In both 5xFAD and 3xTg mouse brain tissue, MOAB-2 co-localized with cathepsin-D, a marker for acidic organelles, further evidence for intraneuronal Aβ, distinct from Aβ associated with the cell membrane. MOAB-2 demonstrated strong intraneuronal and extra-cellular immunoreactivity in 5xFAD and 3xTg mouse brain tissues.

Expand 1 Items

Anti-APP Mouse Monoclonal Antibody (Biotin) [clone: MOAB-2]

Supplier: Biosensis

The amyloid beta peptide is derived from the cleavage of the Amyloid precursor protein (APP) and varies in length from 39 to 43 amino acids. However, the form(s) of amyloid-beta peptide (Aβ) associated with the pathology characteristic of Alzheimer’s disease (AD) remains unclear. In particular, the neurotoxicity of intraneuronal Aβ accumulation is an area of considerable research and controversy principally because antibodies thought to be specific for Aβ have been shown to actually detect intraneuronal APP and not Aβ exclusively.

MOAB-2 (mouse IgG2b) is a pan-specific, high-titer antibody to Aβ residues 1-4 as demonstrated by biochemical and immunohistochemical analyses (IHC), and is highly specific just to amyloid beta peptide. MOAB-2 did not detect APP or APP-CTFs in cell culture media/lysates (HEK-APPSwe or HEK APPSwe/BACE1) or in brain homogenates from transgenic mice expressing 5 familial AD (FAD) mutation (5xFAD mice).

Using IHC on 5xFAD brain tissue, MOAB-2 immunoreactivity co-localized with C-terminal antibodies specific for Aβ40 and Aβ42. MOAB-2 did not co-localize with either N- or C-terminal antibodies to APP. In addition, no MOAB-2-immunreactivity was observed in the brains of 5xFAD/BACE-/- mice, although significant amounts of APP were detected by N- and C-terminal antibodies to APP, as well as by 6E10. In both 5xFAD and 3xTg mouse brain tissue, MOAB-2 co-localized with cathepsin-D, a marker for acidic organelles, further evidence for intraneuronal Aβ, distinct from Aβ associated with the cell membrane. MOAB-2 demonstrated strong intraneuronal and extra-cellular immunoreactivity in 5xFAD and 3xTg mouse brain tissues.

Biosensis now offers biotinylated MOAB-2 antibody allowing more flexibility in experimental design by using the biotin-avidin/streptavidin detection method. Biotinylated MOAB-2 antibody may also help to reduce background staining in difficult-to-stain tissues and increase detection sensitivity. The ability of biotinylated MOAB-2 antibody to detect amyloid beta has been validated by IHC.